IV Synercid

Rhone-Poulenc Rorer is now marketing IV Synercid.

It's the new antibiotic of "last resort"...for vancomycin-resistant Enterococcus faecium (VREF).

Synercid is actually a combination of two antibiotics...quinupristin and dalfopristin.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote